Request for membership to create or review content for BOPA Digital SACT passport

Dear Member,

It has been 12 months since the launch of the “BOPA SACT Verification Passport”.
In order to optimise user experience of the Passport, we need to have new and relevant content.
The Passport working group would like to ask the paying BOPA members for assistance in the creation and review of this content.

How do you contribute?

We request that you register interest to be a creator and/or reviewer of Mock Prescriptions via the following link:

https://www.bopa.org.uk/mock-rx-creator-reviewer-registration/

You can also register within the BOPA SACT Verification Hub in the Contribution to Content tile.

Our mock prescription team will be in touch and will allocate you the required mock prescription content based on your indicated role, level of verification and speciality, and will advise from there.
This is to prevent duplication of entries.

We greatly appreciate any and all contributions to the ongoing use and success of the Passport and encourage all members to get involved in the creation of content.

Please see the relevant supportive SOPs for this process which are saved within the SOP tile of the BOPA SACT Verification Hub.

If you have any queries about this process, please get it touch via email ([email protected])

Kind Regards,

BOPA Passport Pillar

 

Please appreciate these are for UK-wide use and are not unique to any one nation, Trust or cancer centre. Content may not reflect your local practice.

Latest News

By BOPA Exec Committee on 15th September 2025

Invitation to visit the BOPA stand at the BOPA Conference in Belfast

Hello All As an Executive Committee we are looking forward to meeting those of you who are signed up to come to the conference in Belfast next month. The BOPA…

Read article
By BOPA Research subcommittee on 14th September 2025

Survey: Fertility and the use of Immune Checkpoint Inhibitor Therapy (Survey from Royal Marsden Hospital)

Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…

Read article
By Clayton Wong on 8th September 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 21-22 November 2025 | Manchester Central Confirm your free delegate place *free places are only available for registered healthcare…

Read article
By Clayton Wong on 8th September 2025

Opening soon: Abstract submission for the ISOPP International Symposium 2026  

Are you working on an innovative oncology pharmacy project, service evaluation, or research study? Here’s your chance to share it with a global audience! Submit your abstract(s) online by Friday,…

Read article